2-chloro-4,4-dimethyl-3-oxopentanoic acid ethyl ester | 29509-07-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: 2-chloro-4,4-dimethyl-3-oxopentanoic acid ethyl ester
• 英文别名: ethyl 2-chloro-3-oxo-4,4-dimethylpentanoate；2-chloro-4,4-dimethyl-3-oxo-pentanoic acid ethyl ester；α-chloro-pivaloylacetic acid ethyl ester；ethyl 2-chloro-4,4-dimethyl-3-oxo-pentanoate；α-Chlorpivaloylessigsaeureaethylester；Ethyl-2-chloro-4,4-dimethyl-3-ketopentenoat；ethyl 2-chloro-4,4-dimethyl-3-oxopentanoate
• CAS: 29509-07-7
• 化学式: C₉H₁₅ClO₃
• 分子量: 206.669
• InChiKey: XBTXDMIYSKXIGL-UHFFFAOYSA-N

物化性质

• 沸点：
  238.1±20.0 °C(Predicted)
• 密度：
  1.090±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-chloro-4,4-dimethyl-3-oxopentanoic acid ethyl ester 在 manganese(IV) oxide 、 lithium aluminium tetrahydride 、 caesium carbonate 作用下， 以 四氢呋喃 、 水 、 N,N-二甲基甲酰胺 、 丙酮 为溶剂， 反应 24.67h， 生成 (3Z,6Z)-3-[(5-叔丁基-1H-咪唑-4-基)亚甲基]-6-(苯亚甲基)-2,5-哌嗪二酮
  参考文献：
  名称：

  ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THEAPEUTIC USE

  摘要：

  由以下结构（II）表示的化合物已被披露：制备这种化合物的方法也已被披露。还披露了用于治疗各种疾病条件的组合物和方法，包括与血管增殖相关的癌症和非癌症疾病。

  公开号：

  US20080221122A1
• 作为产物：
  描述：

  特戊酰基乙酸乙酯 在 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 生成 2-chloro-4,4-dimethyl-3-oxopentanoic acid ethyl ester
  参考文献：
  名称：

  发现新型二氢咪唑并噻唑衍生物作为p53–MDM2蛋白-蛋白相互作用抑制剂：合成，生物学评估和结构-活性关系

  摘要：

  我们从Nutlins作为最初的线索开始，设计并生成了双环支架，旨在将顺式-双氯苯基部分置于与MDM2可能发生疏水相互作用的等效位置。结果，我们发现了具有二氢咪唑并噻唑支架的新型MDM2抑制剂。在分子模型的辅助下，对二氢咪唑并噻唑支架上侧链的进一步研究导致化合物显示出与Nutlin-3a几乎相同的体外效价。

  DOI：

  10.1016/j.bmcl.2012.08.086

文献信息

• Influence of steric and polar effects in determining the equilibrium position for <i>cis</i>–<i>trans</i>-olefin pairs
  作者：D. V. Gardner、D. E. McGreer

  DOI：10.1139/v70-349

  日期：1970.7.1

  substituted by t-butyl or isopropyl groups at the β-position along with methoxyl, thioethoxyl dimethylamino, chloro, and hydrogen at the other β-position have been prepared. Evaluation of the isomer stability from cis-trans equilibrations achieved catalytically or thermally supports earlier observations'that steric and polar factors maintain a strong tendency for a β-methoxyl group to be trans to a nitrile or

  一系列α,β-不饱和腈和酯在β-位被叔丁基或异丙基取代，在另一个β-位被甲氧基、硫代乙氧基二甲氨基、氯和氢取代。从催化或热上实现的顺反平衡对异构体稳定性的评估支持早期的观察结果，即空间和极性因素保持β-甲氧基转为腈或甲氧基的强烈趋势，即使与叔丁基相反团体。通过用异丙基或叔丁基代替 β-甲基，可以克服在 β-氯巴豆酸甲酯中氯基团优先与碳甲氧基基团反式的趋势。
• [EN] ANALOGS OF DEHYDROPHENYLAHISTINS<br/>[FR] ANALOGUES DE DÉSHYDROPHÉNYLAHISTINES
  申请人：NEREUS PHARMACEUTICALS INC

  公开号：WO2011084962A1

  公开（公告）日：2011-07-14

  Analogs of dehydrophenylahistins are disclosed as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.

  揭示了脱氢苯酚组合物的类似物，以及制备这类化合物的方法。还揭示了用于治疗包括癌症和与血管增殖有关的非癌症疾病等各种疾病状况的组合物和方法。
• HETEROCYCLIC COMPOUND AND p27Kip1 DEGRADATION INHIBITOR
  申请人：Uchida Hiroshi

  公开号：US20130079306A1

  公开（公告）日：2013-03-28

  A novel heterocyclic compound or a salt thereof useful for selectively inhibiting the degradation of p27 Kip1 is provided. The compound or the salt thereof is represented by the following formula (1): wherein A represents an alkyl group, a cycloalkyl group, an aryl group or a heterocyclic group, the group A may have a substituent; the ring B represents a 5- to 8-membered monocyclic heterocyclic ring or a condensed ring containing the monocyclic heterocyclic ring, the ring B may have a substituent; the ring C represents an aromatic ring, the ring C may have a substituent; L represents a linker comprising a main chain having 3 to 5 atoms selected from the group consisting of a carbon atom, a nitrogen atom, an oxygen atom and a sulfur atom, wherein at least one atom in the main chain is a hetero atom selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom, the linker L may have a substituent; and n is 0 or 1.

  提供了一种新型杂环化合物或其盐，用于选择性地抑制p27Kip1的降解。该化合物或其盐由以下式（1）表示：其中A代表烷基、环烷基、芳基或杂环基，基团A可能有取代基；环B代表5至8成员的单环杂环环或包含该单环杂环环的缩合环，环B可能有取代基；环C代表芳香环，环C可能有取代基；L代表包含3至5个原子的主链的连接物，所述原子选自碳原子、氮原子、氧原子和硫原子组成的群，其中主链中的至少一个原子是选自氮原子、氧原子和硫原子组成的杂原子，连接物L可能有取代基；n为0或1。
• Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
  申请人：Palladino A. Michael

  公开号：US20050197344A1

  公开（公告）日：2005-09-08

  Compounds represented by the following structure (I) are disclosed: as are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes are selected from the group consisting of an oxazolecarboxaldeyhyde, imidazolecarboxaldehyde, a benzaldehyde, imidazolecarboxaldehyde derivatives, and benzaldehyde derivatives, thereby forming the above compound wherein R 1 , R 1 ′, R 1 ″, R 2 , R 3 , R 4 , R 5 , and R 6 , X 1 and X 2 , Y, Z, Z 1 , Z 2 , Z 3 , and Z 4 may each be separately defined in a manner consistent with the accompanying description. Compositions and methods for treating vascular proliferation are also disclosed.

  公开了以下结构（I）代表的化合物：制备这种化合物的方法也被公开，其中所述方法包括将二酰基二酮哌嗪与第一醛反应以产生中间化合物；然后将中间化合物与第二醛反应，以产生具有通用结构的化合物类，其中第一醛和第二醛选自氧唑羧醛，咪唑羧醛，苯甲醛，咪唑羧醛衍生物和苯甲醛衍生物组成的群体，从而形成上述化合物，其中R1、R1'、R1''、R2、R3、R4、R5和R6，X1和X2，Y，Z，Z1，Z2，Z3和Z4可以分别根据附带说明书中的描述进行定义。还公开了用于治疗血管增殖的组合物和方法。
• [EN] DEHYDROPHENYLAHISTINS AND ANALOGS THEREOF AND THE SYNTHESIS OF DEHYDROPHENYLAHISTINS AND ANALOGS THEREOF<br/>[FR] DESHYDROPHENYLAHISTINES ET ANALOGUES DE CEUX-CI ET SYNTHESE DE CES DESHYDROPHENYLAHISTINES ET D'ANALOGUES DE CEUX-CI
  申请人：NEREUS PHARMACEUTICALS INC

  公开号：WO2004054498A2

  公开（公告）日：2004-07-01

  Compounds represented by structure (I) are disclosed, as are methods for making such compounds, wherein said methods comprise reacting a diacyldiketopiperazine with a first aldehyde to produce an intermediate compound; and reacting the intermediate compound with a second aldehyde to produce the class of compounds with the generic structure, where the first aldehyde and the second aldehydes are selected from the group consisting of an oxazolecarboxaldeyhyde, imidazolecarboxaldehyde, a benzaldehyde, imidazolecarboxaldehyde derivatives, and benzaldehyde derivatives, thereby forming the above compound wherein R1, R1', R1'', R2, R3, R4, R5, and R6, X1 and X2, Y, Z, Z1, Z2, Z3, and Z4 may each be separately defined in a manner consistent with the accompanying description. Compositions and methods for treating cancer and fungal infection are also disclosed.

  本发明揭示了结构（I）所代表的化合物，以及制备此类化合物的方法，其中所述方法包括将双酰基二酮哌嗪与第一醛反应以产生中间化合物；并将中间化合物与第二醛反应以产生具有通用结构的化合物类别，其中第一醛和第二醛选自羧醛噁唑，咪唑羧醛，苯甲醛，咪唑羧醛衍生物和苯甲醛衍生物的群体，从而形成上述化合物，其中R1，R1'，R1''，R2，R3，R4，R5和R6，X1和X2，Y，Z，Z1，Z2，Z3和Z4可以分别按照所附说明书的方式定义。本发明还揭示了用于治疗癌症和真菌感染的组合物和方法。